Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05015504 · ClinicalTrials.gov registry record · NA

Application of Time Restriction Feeding in Patients With Type 2 Diabetes Mellitus

A NA study of Type 2 Diabetes, sponsored by OhioHealth.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05015504 is a NA study of Type 2 Diabetes that is active but no longer recruiting, run by OhioHealth. The registered enrollment target is 30 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05015504, a NA study of Type 2 Diabetes, is active but no longer recruiting, sponsored by OhioHealth.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

In this 3-week interventional study, the investigators hypothesize that therapeutic Time-Restricted Feeding in patients with poorly controlled Type 2 diabetes mellitus (T2DM) can improve their mean glucose or estimated glycated hemoglobin levels with the same dose, or even reduced dose, of antidiabetics.

Conditions Studied

Interventions

  • BEHAVIORAL Time restricted feeding

Study Locations (1)

Ohio

  • OhioHealth Castrop Health Center - Athens

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-02-10
Est. Completion 2025-09
Phase NA

Sponsor

OhioHealth

20 total trials

What the Registry Record Tells You About NCT05015504

The ClinicalTrials.gov registry entry for NCT05015504 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is OhioHealth, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Time restricted feeding is the first listed.

NCT05015504 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05015504 about?

NCT05015504 is a clinical study titled "Application of Time Restriction Feeding in Patients With Type 2 Diabetes Mellitus". In this 3-week interventional study, the investigators hypothesize that therapeutic Time-Restricted Feeding in patients with poorly controlled Type 2 diabetes mellitus (T2DM) can improve their mean glucose or estimated glycated hemoglobin levels with the same dose, or even reduced dose, of antidiabe...

What is the current status of trial NCT05015504?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-02-10. Estimated completion is 2025-09.

What conditions does trial NCT05015504 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT05015504?

The interventions under investigation include: Time restricted feeding (BEHAVIORAL).

Who is sponsoring clinical trial NCT05015504?

This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05015504 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.